Journal of the American Society of Nephrology, Vol 7, 2682-2688, Copyright © 1996 by American Society of Nephrology

REGULAR ARTICLES

Biodistribution and clearance of 99mTc-labeled Arg-Gly-Asp (RGD) peptide in rats with ischemic acute renal failure

E Noiri, MS Goligorsky, GJ Wang, J Wang, CJ Cabahug, S Sharma, BA Rhodes and P Som
Department of Medicine, State University of New York at Stony Brook 11794, USA.

Based on the previous demonstration of a renoprotective effect of arginine-glycine-aspartic acid (RGD) peptides in acute renal failure, experiments were designed to test the distribution and renal accumulation of the peptide. To accomplish this goal, in this study, RGD peptide was radiolabeled and its biodistribution and renal accumulation was determined in rats with ischemic acute renal failure (ARF). 99mTc-RGD with or without 111In-DTPA were injected intravenously in control and ARF rats. Various organs were dissected at different times after injection and subjected to gamma-scintillation counting and autoradiography (ARG). Blood clearance of 99mTc-RGD was rapid, with t1/2 < 10 min, and unchanged in ARF compared with control rats. Kidneys retained the largest portion of the injected dose in both control and ARF rats, as detected using scintillation counting and whole-body ARG (10.56 +/- 1.05% and 10.12 +/- 3.16% injected dose/g wet weight, respectively). Renal ARG revealed a significant increase in binding to the cortex in ARF kidneys, compared with that of control kidneys. Given the differences in renal blood flow and GFR in control and postischemic kidneys, the next series of experiments was performed with two radiopharmaceuticals, 99mTc-RGD and 111In-DTPA. The ratio of 99mTc- RGD:111In-DTPA was increased more than three-fold in ARF kidneys compared with control kidneys (2.7 +/- 0.15 versus 0.8 +/- 0.19, respectively). The results indicate that (1) RGD peptide undergoes a rapid clearance predominantly via the renal route; (2) despite a significant reduction in the renal perfusion, 99mTc-RGD peptide accumulates in the postischemic kidney; (3) this is consistent with the hypothesis on the involvement of RGD-recognizing integrins in the development of tubular obstruction in renal ischemia.

This article has been cited by other articles:

				S. Elitok, S. V. Brodsky, D. Patschan, T. Orlova, K. M. Lerea, P. Chander, and M. S. Goligorsky Cyclic arginine-glycine-aspartic acid peptide inhibits macrophage infiltration of the kidney and carotid artery lesions in apo-E-deficient mice Am J Physiol Renal Physiol, January 1, 2006; 290(1): F159 - F166. [Abstract] [Full Text] [PDF]

				M. S. Goligorsky The concept of cellular "fight-or-flight" reaction to stress Am J Physiol Renal Physiol, April 1, 2001; 280(4): F551 - F561. [Abstract] [Full Text] [PDF]

				E. Noiri, T. Yokomizo, A. Nakao, T. Izumi, T. Fujita, S. Kimura, and T. Shimizu An in vivo approach showing the chemotactic activity of leukotriene B4 in acute renal ischemic-reperfusion injury PNAS, January 18, 2000; 97(2): 823 - 828. [Abstract] [Full Text] [PDF]

				K.-P. Yip and D. J. Marsh An Arg-Gly-Asp peptide stimulates constriction in rat afferent arteriole Am J Physiol Renal Physiol, November 1, 1997; 273(5): F768 - F776. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673